Chest wrinkle filler put to the test: will it mess up your mammogram?
NCT ID NCT07086248
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether Radiesse, a dermal filler injected into the chest area to treat wrinkles, can interfere with mammograms or breast ultrasounds. Thirty adult women will receive diluted Radiesse injections and then undergo breast imaging to see if the filler hides breast tissue or causes false alarms. The goal is to ensure this cosmetic treatment does not compromise breast cancer detection.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Radiesse (calcium hydroxylapatite) diluted with saline
- What this could lead to
- If successful, this study could confirm that Radiesse dilute does not interfere with breast cancer screening, reassuring women who use this cosmetic treatment.
- What could go wrong
- This is a small, early-stage safety study with only 30 participants, so results may not apply to everyone. It does not test effectiveness for wrinkles.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Jul 2025
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants seeking improvement of moderate to severe décolleté wrinkles. * Participant is willing to undergo up to three bilateral mammograms and up to four bilateral ultrasound procedures. Exclusion Criteria: * Any pre-existing serious disease or disorder of the breast tissue that may confound interpretation of radiographic and/or ultrasound imaging (example., participants with a history of breast cancer or an immediate family history of breast cancer \[that is., mother, sister, and/or daughter\], pathogenic or likely pathogenic breast cancer (BRCA) gene variant, calcifications and/or microcalcifications detected on previous mammography \[up to three years prior to study start, if available\]). * Present uncontrolled malignant disease. * Any condition that would caution against receiving additional radiation exposure in the breasts. * Any previous surgery, including plastic surgery or permanent surgical implant, or previous non-surgical treatment in the planned in the treatment area and in the breasts.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Décolleté wrinkles are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Merz Investigative Site
Alpharetta, Georgia, 30005, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.